These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12120971)

  • 1. The increasing prevalence of childhood sickle-cell disease in Ireland.
    McMahon C; Callaghan CO; O'Brien D; Smith OP
    Ir J Med Sci; 2001; 170(3):183-5. PubMed ID: 12120971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease: time for a targeted neonatal screening programme.
    Gibbons C; Geoghegan R; Conroy H; Lippacott S; O'Brien D; Lynam P; Langabeer L; Cotter M; Smith O; McMahon C
    Ir Med J; 2015 Feb; 108(2):43-5. PubMed ID: 25803954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of sickle cell disease in the Netherlands.
    Aluoch JR
    Trop Geogr Med; 1984 Jun; 36(2):115-22. PubMed ID: 6332394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
    Olabode JO; Shokunbi WA
    West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease is common in sickle cell disease: a cross-sectional study in the Tema Metropolis, Ghana.
    Ephraim RK; Osakunor DN; Cudjoe O; Oduro EA; Asante-Asamani L; Mitchell J; Agbodzakey H; Adoba P
    BMC Nephrol; 2015 May; 16():75. PubMed ID: 26021375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric sickle cell retinopathy: correlation with clinical factors.
    Rosenberg JB; Hutcheson KA
    J AAPOS; 2011 Feb; 15(1):49-53. PubMed ID: 21397806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteomyelitis in sickle cell haemoglobinopathy with elevated fetal haemoglobin.
    Narchi H
    Ann Trop Paediatr; 2000 Mar; 20(1):70-5. PubMed ID: 10824218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study.
    Downes SM; Hambleton IR; Chuang EL; Lois N; Serjeant GR; Bird AC
    Ophthalmology; 2005 Nov; 112(11):1869-75. PubMed ID: 16171867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell disease in Britain.
    Brozović M; Anionwu E
    J Clin Pathol; 1984 Dec; 37(12):1321-6. PubMed ID: 6511979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
    Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
    Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse neurological outcomes in Nigerian children with sickle cell disease.
    Lagunju IA; Brown BJ
    Int J Hematol; 2012 Dec; 96(6):710-8. PubMed ID: 23129067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profile of sickle cell disease in Orissa.
    Kar BC; Devi S
    Indian J Pediatr; 1997; 64(1):73-7. PubMed ID: 10771815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Profiles of Children With Sickle Cell Anaemia Presenting With Acute Clinical Events: A Single-Center Study.
    Singh A; Bokade C; Tirpude B; Suryawanshi MM; Rohadkar LA
    Cureus; 2023 May; 15(5):e39008. PubMed ID: 37378258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative screening for sickle cell disease in children: clinical implications.
    Crawford MW; Galton S; Abdelhaleem M
    Can J Anaesth; 2005 Dec; 52(10):1058-63. PubMed ID: 16326676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell diseases: What can nuclear medicine offer?
    Niccoli Asabella A; Altini C; Nappi AG; Lavelli V; Ferrari C; Marzullo A; Loiodice A; Rubini G
    Hell J Nucl Med; 2019; 22(1):2-3. PubMed ID: 30843001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
    Adeyemo T; Ojewunmi O; Oyetunji A
    Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of acute events among patients with sickle cell disease in relation to early or late initiation of care at a specialist center: evidence from a retrospective cohort study.
    Rankine-Mullings AE; Logan TM; King LG; Cunningham-Myrie CA; Scott CR; Knight-Madden JM
    BMC Pediatr; 2020 Aug; 20(1):373. PubMed ID: 32770992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of sickle cell disease from the socio-demographic triangle - a Nigerian single-institution retrospective study.
    Nwabuko OC; Onwuchekwa U; Iheji O
    Pan Afr Med J; 2022; 41():161. PubMed ID: 35655681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of sickle cell disease in Cape Town.
    Wonkam A; Ponde C; Nicholson N; Fieggen K; Ramessar R; Davidson A
    S Afr Med J; 2012 Jun; 102(9):752-4. PubMed ID: 22958698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.